Conditionally Replicative Adenovirus Expressing a Targeting Adapter Molecule Exhibits Enhanced Oncolytic Potency on CAR-deficient Tumors

Gene Therapy - United Kingdom
doi 10.1038/sj.gt.3302103
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Conditionally Replicative Adenovirus That Codes for a TK-GFP Fusion Protein (Ad5Δ24TK-Gfp) for Evaluation of the Potency of Oncolytic Virotherapy Combined With Molecular Chemotherapy

International Journal of Molecular Medicine
MedicineGenetics
2006English

Cancer Therapy With a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors

Clinical Cancer Research
Cancer ResearchOncology
2004English

Current Approaches to Increase CAR T Cell Potency in Solid Tumors: Targeting the Tumor Microenvironment

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

639. Oncolytic Adenovirus Expressing IFN Alpha Works Synergistically With Chemoradiation

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

Transcriptional Targeting of Conditionally Replicating Adenovirus to Dividing Endothelial Cells

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2002English

Oncolytic Virus Expressing RANTES and IL-15 Enhances Function of CAR-modified T Cells in Solid Tumors

OncoImmunology
OncologyAllergyImmunology
2015English

Immunotherapeutic Intervention With Oncolytic Adenovirus in Mouse Mammary Tumors

OncoImmunology
OncologyAllergyImmunology
2015English

A Fully Replication-Competent Adenovirus Vector With Enhanced Oncolytic Properties

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2010English

An Oncolytic Adenovirus That Expresses the HAb18 and Interleukin 24 Genes Exhibits Enhanced Antitumor Activity in Hepatocellular Carcinoma Cells

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy